Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiac Insight
Bellevue, Washington, United States
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Cardiac Insight's Cardea SOLO and Cardea 20/20 ECG devices are FDA-cleared, in commercial use in the US, South Korea, and Asia-Pacific. These solutions allow rapid, in-clinic analysis and reporting of cardiac rhythms—primarily for arrhythmia, AFib, and athletic cardiac screening—with proprietary algorithms and no clinically active therapeutic trials.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceWearable deviceSoftware
- Industry
- Physiological Monitoring
02
Partnerships
Dreamtech (i.SigNal brand for Asia-Pacific distribution)
Beyond the preview
Go deeper on Cardiac Insight.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cardiac Insight.